These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2561924

  • 41. In vitro studies with R 51,211 (itraconazole).
    Espinel-Ingroff A, Shadomy S, Gebhart RJ.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):5-9. PubMed ID: 6089654
    [Abstract] [Full Text] [Related]

  • 42. Effects of ketoconazole and itraconazole on growth and sterol synthesis in Pityrosporum ovale.
    Marichal P, Gorrens J, Van Cutsem J, Van Gerven F, Vanden Bossche H.
    J Med Vet Mycol; 1986 Dec; 24(6):487-9. PubMed ID: 3033190
    [Abstract] [Full Text] [Related]

  • 43. Effects of itraconazole on phagocytosis and killing of Candida glabrata by polymorphonuclear leucocytes from guinea pigs.
    Xhonneux B, Jansen T, Borgers M, Odds FC.
    J Antimicrob Chemother; 1992 Aug; 30(2):181-8. PubMed ID: 1328134
    [Abstract] [Full Text] [Related]

  • 44. Itraconazole, a new triazole that is orally active in aspergillosis.
    Van Cutsem J, Van Gerven F, Van de Ven MA, Borgers M, Janssen PA.
    Antimicrob Agents Chemother; 1984 Oct; 26(4):527-34. PubMed ID: 6097167
    [Abstract] [Full Text] [Related]

  • 45. Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole.
    Vuddhakul V, Mai GT, McCormack JG, Seow WK, Thong YH.
    Int J Immunopharmacol; 1990 Oct; 12(6):639-45. PubMed ID: 2177039
    [Abstract] [Full Text] [Related]

  • 46. The effect of ketoconazole and itraconazole on the filamentous form of Pityrosporum ovale.
    Faergemann J, Borgers M.
    Acta Derm Venereol; 1990 Oct; 70(2):172-6. PubMed ID: 1969209
    [Abstract] [Full Text] [Related]

  • 47. Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.
    Brummer E, Bhagavathula PR, Hanson LH, Stevens DA.
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2487-92. PubMed ID: 1336949
    [Abstract] [Full Text] [Related]

  • 48. Comparative morphological and biological studies on the itraconazole- and ketoconazole-resistant mutants of Cryptococcus neoformans.
    Iwata K, Yamashita T, Ohsumi M, Baba M, Naito N, Taki A, Yamada N.
    J Med Vet Mycol; 1990 Nov; 28(1):77-90. PubMed ID: 2163443
    [Abstract] [Full Text] [Related]

  • 49. Itraconazole: pharmacologic studies in animals and humans.
    Van Cauteren H, Heykants J, De Coster R, Cauwenbergh G.
    Rev Infect Dis; 1987 Nov; 9 Suppl 1():S43-6. PubMed ID: 3027845
    [Abstract] [Full Text] [Related]

  • 50. Antibacterial and antifungal agents. XV. Synthesis and antifungal activity of structural analogues of bifonazole and ketoconazole.
    Stefancich G, Artico M, Ortar G, Silvestri R, Simonetti G, Apuzzo G, Artico M.
    Arch Pharm (Weinheim); 1992 Nov; 325(11):687-94. PubMed ID: 1485835
    [Abstract] [Full Text] [Related]

  • 51. Comparison of itraconazole and ketoconazole in the treatment of experimental candidal vaginitis.
    Sobel JD, Muller G.
    Antimicrob Agents Chemother; 1984 Aug; 26(2):266-7. PubMed ID: 6091538
    [Abstract] [Full Text] [Related]

  • 52. [Skin and mucosal candidiasis. Typification of species isolated from a limited caseload and in vitro study of the activity of some antifungal drugs on isolated strains].
    Pezzarossa E, Bossano A, Cervetti O, Forte M, Mele M.
    G Ital Dermatol Venereol; 1988 Dec; 123(12):665-9. PubMed ID: 3253188
    [No Abstract] [Full Text] [Related]

  • 53. Lack of immunosuppression by ketoconazole and itraconazole.
    Cools M, Aerts F, Van Wauwe J.
    Int J Immunopharmacol; 1992 Aug; 14(6):1011-7. PubMed ID: 1330944
    [Abstract] [Full Text] [Related]

  • 54. Itraconazole treatment of experimental systemic candidiasis in male rats.
    Yozwiak ML, Galgiani JN.
    J Med Vet Mycol; 1987 Apr; 25(2):125-6. PubMed ID: 3037058
    [Abstract] [Full Text] [Related]

  • 55. Effects of itraconazole on mitogen stimulated human mononuclear leucocytes.
    Manzella JP, Clark J.
    J Antimicrob Chemother; 1989 Jan; 23(1):95-7. PubMed ID: 2545655
    [Abstract] [Full Text] [Related]

  • 56. Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole.
    Warnock DW, Turner A, Burke J.
    J Antimicrob Chemother; 1988 Jan; 21(1):93-100. PubMed ID: 2833490
    [Abstract] [Full Text] [Related]

  • 57. Comparisons of ketoconazole, PR 969-566, PR 967-234, and PR 967-248 as antifungals in vitro and in the rat model of candidal vaginitis based on efficacy/safety profiles.
    Palmer GC, Ordy JM, Simmons RD, Strand JC, Mullen GB, Kinsolving CR, St Georgiev V, Allen SD.
    Ann N Y Acad Sci; 1988 Jan; 544():387-91. PubMed ID: 3274919
    [No Abstract] [Full Text] [Related]

  • 58. Itraconazole therapy for disseminated candidiasis in a very low birthweight neonate.
    Bhandari V, Narang A, Kumar B, Singh M, Nair PM, Bhakoo ON.
    J Paediatr Child Health; 1992 Aug; 28(4):323-4. PubMed ID: 1323317
    [Abstract] [Full Text] [Related]

  • 59. [Antifungal activity of nitroxoline].
    Hernández JM, Llosá J, Martínez A.
    Enferm Infecc Microbiol Clin; 1991 Aug; 9(7):439-40. PubMed ID: 1799618
    [No Abstract] [Full Text] [Related]

  • 60. Use of itraconazole in a patient with chronic mucocutaneous candidiasis.
    Burke WA.
    J Am Acad Dermatol; 1989 Dec; 21(6):1309-10. PubMed ID: 2555403
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.